LIPELLA PHARMACEUTICALS INC. (LIPO): going-concern / distress — Lipella Pharmaceuticals files Chapter 11 bankruptcy, plans 363 sale process

LIPELLA PHARMACEUTICALS INC.

Filed voluntary Chapter 11 petition in Western District of Pennsylvania on March 30, 2026.
Company intends to pursue a 363 sale process to maximize value for creditors.
Seeks customary first-day relief to continue operations, including payroll and cash management.
Company cautions trading in common stock is highly speculative and may not reflect recovery for holders.

Key facts

Extracted from this filing and checked against the source text.

Distress & Bankruptcy SEC 8-K Item 1.03 confidence 0.9

LIPELLA PHARMACEUTICALS INC. entered chapter 11 in United States Bankruptcy Court for the Western District of Pennsylvania.

Proceeding: chapter 11
Court: United States Bankruptcy Court for the Western District of Pennsylvania

Exact text from the filing

On [Filing Date] , [Company Name, Inc.] (the “Company”) and certain of its subsidiaries (collectively, the “Debtors”) filed voluntary petitions for relief under Chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the Western District of Pennsylvania (the “Bankruptcy Court”).

View on SEC.gov

Browse all distress & bankruptcy →

LIPELLA PHARMACEUTICALS INC. filing history →

Source: SEC EDGAR

accession 0001753926-26-000577

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.